BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2005
View Archived Issues
PTC-124 begins phase II study for cystic fibrosis with FDA funding
Read More
Study to compare Xyotax and paclitaxel in women with advanced NSCLC
Read More
Exelixis and Bristol-Myers Squibb collaborate on LXR-targeting therapies
Read More
First milestone in Evotec and Takeda's Alzheimer's collaboration
Read More
Cephalon to acquire Zeneus Holdings
Read More
CA4P to be studied in combination with Avastin
Read More
BioDiem to study BDM-E in patients with diabetic macula edema
Read More
Inamed receives irrevocable offer and merger agreement from Allergan
Read More
First clinical trial of L-annamycin in relapsed and refractory ALL
Read More
PRTX-100 tested for first time in humans
Read More
Novelos to advance NOV-002 into pivotal phase III study for advanced NSCLC
Read More
Borean Pharma establishes proof-of-concept for TNF-alpha antagonist
Read More
New ROCK inhibitor displays antiangiogenic and antitumor effects
Read More
PK and tolerability profile of darunavir/low-dose ritonavir in humans
Read More
MK-0518: An effective short-term therapy in HIV-1 patients
Read More
Breast cancer responses not increased with tipifarnib-letrozole combination
Read More
ZK-EPO active in human breast cancer models
Read More
Scutellaria barbata extract (BZL-101) evaluated in phase I breast cancer trial
Read More
TAS-108 active, with acceptable toxicity, in postmenopausal breast cancer patients
Read More
Targeting Mcl-1 for leukemia
Read More
Xyrem launched in Germany for cataplexy in adult with narcolepsy
Read More
NDA filed for NRP-104 in ADHD
Read More
New analgesic agents reported in patent literature
Read More
Companies patent novel agents for gastrointestinal disorders
Read More
New agents reported with potential in treatment of Parkinson's disease and other disorders
Read More